EDX Medical has developed a new non-invasive prostate cancer test it hopes will transform diagnosis and detection of the disease. The purpose of the Cambridge, UK-based company's test is to identify ...

This announcement contains inside information as stipulated under the UK version of the Market Abuse Regulation No 596/2014 which is part of English law by virtue of the European (Withdrawal) Act 2018 ...

EDX Medical Group plc announced that it has entered into an initial three-year agreement with the Arnold Clark Group to provide the EDX Medical health and wellbeing screening programme to its ...

CAMBRIDGE, England--(BUSINESS WIRE)--Scientists in Cambridge have developed a new ‘super test’ for prostate cancer in an effort to revolutionise screening and diagnosis of the disease and accelerate ...